113 related articles for article (PubMed ID: 9480143)
1. [Ex-vivo bleeding time as a control for platelet transfusion].
Söhngen D; Hattstein E; Heyll A; Kuntz BM; Meckenstock G; Schneider W
Beitr Infusionsther Transfusionsmed; 1994; 32():459-66. PubMed ID: 9480143
[TBL] [Abstract][Full Text] [Related]
2. Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.
Neukirchen J; Blum S; Kuendgen A; Strupp C; Aivado M; Haas R; Aul C; Gattermann N; Germing U
Eur J Haematol; 2009 Nov; 83(5):477-82. PubMed ID: 19548919
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
[TBL] [Abstract][Full Text] [Related]
4. [Improvement of bleeding tendency and normalized platelet count increment following splenectomy in a patient with refractory anemia].
Kawai Y; Fukushima T; Ookura K; Yoshio N; Yamauchi T; Nakayama T; Tohyama K; Wano Y; Tsutani H; Ueda T; Nakamura T
Rinsho Ketsueki; 1997 Jun; 38(6):532-8. PubMed ID: 9248330
[TBL] [Abstract][Full Text] [Related]
5. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
[TBL] [Abstract][Full Text] [Related]
6. [Determining clinical effectiveness of plasmapheresis thrombocyte preparations].
Kirsten K
Beitr Infusionsther; 1992; 30():149-51. PubMed ID: 1284693
[TBL] [Abstract][Full Text] [Related]
7. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
[TBL] [Abstract][Full Text] [Related]
8. Platelet transfusion therapy in thrombocytopaenia of haematologic malignancies.
Charak BS; Rao K; Parikh PM; Rawat RS; Nair CN; Advani SH
J Assoc Physicians India; 1989 Mar; 37(3):201-3. PubMed ID: 2768161
[TBL] [Abstract][Full Text] [Related]
9. Cryopreserved autologous platelet transfusions in alloimmunized patients with acute leukemia.
Wiesneth M; Koerner K; Funke I; Seifried E; Cardoso M; Heimpel H; Kubanek B
Beitr Infusionsther; 1992; 30():297-300. PubMed ID: 1284720
[TBL] [Abstract][Full Text] [Related]
10. Platelet function testing to assess effectiveness of platelet transfusion therapy.
Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN
Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745
[TBL] [Abstract][Full Text] [Related]
11. [Thrombocyte transfusion: clinical aspects, follow-up and complications].
Söhngen D; Schneider W
Klin Wochenschr; 1991 Jun; 69(9):379-86. PubMed ID: 1921239
[TBL] [Abstract][Full Text] [Related]
12. Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion.
Vavricka SR; Walter RB; Irani S; Halter J; Schanz U
Ann Hematol; 2003 Sep; 82(9):570-3. PubMed ID: 12904898
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
Navarro JT; Hernández JA; Ribera JM; Sancho JM; Oriol A; Pujol M; Millá F; Feliu E
Haematologica; 1998 Nov; 83(11):998-1000. PubMed ID: 9864920
[TBL] [Abstract][Full Text] [Related]
14. Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia.
Ganti AK; Landmark JD; Kessinger A; Smith LM; Tarantolo SR
In Vivo; 2006; 20(4):559-63. PubMed ID: 16900790
[TBL] [Abstract][Full Text] [Related]
15. Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy.
Aderka D; Praff G; Santo M; Weinberger A; Pinkhas J
Am J Med Sci; 1986 Mar; 291(3):147-51. PubMed ID: 3456706
[TBL] [Abstract][Full Text] [Related]
16. Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection.
Lye DC; Lee VJ; Sun Y; Leo YS
Clin Infect Dis; 2009 May; 48(9):1262-5. PubMed ID: 19292665
[TBL] [Abstract][Full Text] [Related]
17. The clinical impact of platelet refractoriness: correlation with bleeding and survival.
Kerkhoffs JL; Eikenboom JC; van de Watering LM; van Wordragen-Vlaswinkel RJ; Wijermans PW; Brand A
Transfusion; 2008 Sep; 48(9):1959-65. PubMed ID: 18564396
[TBL] [Abstract][Full Text] [Related]
18. Prospective observational study of low thresholds for platelet transfusion in adult dengue patients.
Thomas L; Kaidomar S; Kerob-Bauchet B; Moravie V; Brouste Y; King JP; Schmitt S; Besnier F; Abel S; Mehdaoui H; Plumelle Y; Najioullah F; Fonteau C; Richard P; Césaire R; Cabié A
Transfusion; 2009 Jul; 49(7):1400-11. PubMed ID: 19320862
[TBL] [Abstract][Full Text] [Related]
19. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
20. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia.
Webert K; Cook RJ; Sigouin CS; Rebulla P; Heddle NM
Haematologica; 2006 Nov; 91(11):1530-7. PubMed ID: 17043016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
